141 related articles for article (PubMed ID: 24463897)
1. Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity.
Cordeiro L; Campos JM; de Paula PS; Vilar L; Lopes E; de Arruda PC; Ramos A; Ferraz Á
Arq Bras Cir Dig; 2013; 26 Suppl 1():39-42. PubMed ID: 24463897
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
3. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
[TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings.
Oliveira CP; Faintuch J; Rascovski A; Furuya CK; Bastos Mdo S; Matsuda M; Della Nina BI; Yahnosi K; Abdala DS; Vezozzo DC; Alves VA; Zilberstein B; Garrido AB; Halpern A; Carrilho FJ; Gama-Rodrigues JJ
Obes Surg; 2005 Apr; 15(4):502-5. PubMed ID: 15946429
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass.
Guajardo-Salinas GE; Hilmy A
Obes Surg; 2010 Dec; 20(12):1647-53. PubMed ID: 19957049
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery.
Losekann A; Weston AC; Carli LA; Espindola MB; Pioner SR; Coral GP
Arq Gastroenterol; 2013; 50(4):285-9. PubMed ID: 24474231
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM
Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616
[TBL] [Abstract][Full Text] [Related]
10. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.
Mattar SG; Velcu LM; Rabinovitz M; Demetris AJ; Krasinskas AM; Barinas-Mitchell E; Eid GM; Ramanathan R; Taylor DS; Schauer PR
Ann Surg; 2005 Oct; 242(4):610-7; discussion 618-20. PubMed ID: 16192822
[TBL] [Abstract][Full Text] [Related]
11. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity.
Duchini A; Brunson ME
Transplantation; 2001 Jul; 72(1):156-9. PubMed ID: 11468551
[TBL] [Abstract][Full Text] [Related]
12. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
15. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
17. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.
Kroh M; Liu R; Chand B
Surg Endosc; 2007 Nov; 21(11):1957-60. PubMed ID: 17479322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
